Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.840
+0.020 (0.71%)
Apr 20, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Employees
Acumen Pharmaceuticals had 61 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
61
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,989,098
Market Cap
205.08M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 61 | 0 | - | 60 | 1 |
| Dec 31, 2024 | 61 | 9 | 17.31% | 61 | 0 |
| Dec 31, 2023 | 52 | 12 | 30.00% | 51 | 1 |
| Dec 31, 2022 | 40 | 23 | 135.29% | 39 | 1 |
| Dec 31, 2021 | 17 | 10 | 142.86% | 14 | 3 |
| Mar 31, 2021 | 7 | - | - | 7 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| ProQR Therapeutics | 187 |
| Tonix Pharmaceuticals Holding | 142 |
| Heron Therapeutics | 128 |
| Precision BioSciences | 68 |
| Korro Bio | 58 |
| Enlivex | 34 |
| Whitehawk Therapeutics | 23 |
ABOS News
- 25 days ago - Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights - GlobeNewsWire
- 4 weeks ago - Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026 - GlobeNewsWire
- 5 weeks ago - Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio - GlobeNewsWire
- 5 weeks ago - Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum - GlobeNewsWire
- 8 months ago - Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 8 months ago - Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 9 months ago - Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025 - GlobeNewsWire
- 9 months ago - JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform - Business Wire